Finally, the in vivo experiments on xenograft models further verified the cancerogenic effect of DLGAP1-AS1 on tumor growth and metastasis of HCC, suggesting the potential clinical value of DLGAP1-AS1. Here, DLGAP1 is linked to neoplasm.